ICHP Position Statement - Medical Cannabis (Marijuana)

ICHP supports the following regarding the use of medical cannabis:

  • ICHP supports that the DEA and/or Congress review the classification of cannabis and consider a schedule that allows for further research of cannabis and its individual components
  • ICHP advocates for further research and clinical trials involving the safety and efficacy of medical cannabis and its individual components.
  • ICHP advocates for the standardization of cannabis containing products and its individual active components.
  • ICHP advocates for the development of screening methods to assess the level of impairment caused by cannabis use, as is applicable to particular duties (i.e operation of motor vehicles, workplace duties)
  • ICHP supports pharmacist and technician education on the current Federal and State regulations pertaining to the use of medical cannabis
  • ICHP supports pharmacist education on medical information or literature pertaining to medical cannabis in order to better counsel patients and families with questions or concerns.  
  • ICHP advocates the education of purchasers on known health risks associated with the use of cannabis at the time of purchase.

In addition, ICHP opposes the dispensing of cannabis for non-medicinal use.

Revised 01/2021